Expect more with Siegfried as your preferred partner
Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value.
Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value.
April 18, 2013
Decision to distribute CHF 1.20 per share Zofingen, 18 April 2013 – The Annual Shareholders Meeting of Siegfried Holding AG ... Read more »
January 11, 2013
At the Shareholders’ Meeting scheduled for 18 April 2013, the Board of Directors of Siegfried Holding AG (SIX: SFZN) will propose ... Read more »
Stock Quote (SFZN)
AMP Alliance Medical Products
Upcoming Events
- > Publication Half Year Results 2013, 26th August, 2013
- > Chemspec in Munich, 5 - 6 June, 2013
- > CPhI Frankfurt, October 22 - 24, 2013